---
title: The impact of metastatic sites on survival Rates and predictors of extended
  survival in patients with metastatic pancreatic cancer
date: '2024-07-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38969544/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240706182815&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: While synchronous liver metastases are associated with worse
  outcomes than lung-only and lymph node-only metastases, this predictive value is
  diminished after six months. Therefore, treatment decisions beyond this time should
  not primarily depend on the metastatic site. Extended survival is possible in a
  small subset of patients with favorable tumor biology and good conditional status,
  who are more likely to undergo aggressive ...'
disable_comments: true
---
CONCLUSION: While synchronous liver metastases are associated with worse outcomes than lung-only and lymph node-only metastases, this predictive value is diminished after six months. Therefore, treatment decisions beyond this time should not primarily depend on the metastatic site. Extended survival is possible in a small subset of patients with favorable tumor biology and good conditional status, who are more likely to undergo aggressive ...